APEIRON Biologics is a privately-held European biotech company based in Vienna, Austria, focused on the discovery and development of novel cancer immunotherapies and respiratory diseases. APEIRON received EU marketing approval for APN311 (Dinutuximab beta, Qarziba®) in 2017 for the treatment of pediatric neuroblastoma patients and out-licensed global, exclusive rights for this product to EUSA Pharma Ltd.. APEIRON now leverages its proprietary master checkpoint blockade mechanism to enable the human body’s natural defense mechanisms to fight the tumor. APEIRON’s clinical program APN401 is a first-in-class autologous cellular therapy to strengthen immune reactivity via an intracellular master checkpoint, Cbl-b. APEIRON’s APN01 (rhACE2) is starting a Phase II trial in Europe to treat COVID-19. APEIRON’s projects and technologies are bolstered by a strong patent portfolio. Its development expertise is validated through partnerships with leading pharmaceutical companies and academic institutions.
We are searching for an enthusiastic
Communications & Alliance Manager (m/f)
full time/part time
For the position we offer at least an annual gross salary of € 62.000, -. The actual remuneration package will be based on your professional experience, qualification and skills.
If you enjoy working in a dynamic, motivated and international team with an open and friendly corporate culture we are looking forward to receiving your application (incl. Curriculum vitae and photo).
Contact: Human Resources, Elena Pretterebner
1030 Vienna, Campus-Vienna-Biocenter 5